No attachments available.
Accreditation services from Foundation for the Accreditation Council of Cellular Therapy (FACT)
Contact and place of performance
Darlena Rivera
USA
Notice of Intent to Sole Source The Medical Readiness Contracting Office-West, JBSA - Fort Sam Houston, Texas intends to award a firm-fixed-price sole source contract to Foundation for the Accreditation Council of Cellular Therapy (FACT) for Department of Medicine for continued accreditation for the Bone Marrow Program at Brooke Army Medical Center, JBSA Fort Sam Houston, Texas. The contract will be awarded to the FA...
View moreThe Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government.
NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE IN WRITING TO THE BELOW POCs ON OR BEFORE 20 MAY 2026 BY 11:00 PM CST IN ORDER TO BE CONSIDERED. IT IS THE GOVERNMENT’S INTENT TO AWARD THE CONTRACT TO FACT ON OR AFTER 22 MAY 2026.
Darlena Rivera Purchasing Agent
Medical Readiness Contracting Office – West
Rashonda Jones Contracting Officer
Medical Readiness Contracting Office- West
The Medical Readiness Contracting Office-West at JBSA - Fort Sam Houston, Texas, intends to award a firm-fixed-price sole source contract to the Foundation for the Accreditation Council of Cellular Therapy (FACT). This requirement supports the Department of Medicine by providing continued accreditation for the Bone Marrow Program at Brooke Army Medical Center. The contract, identified under solicitation number 12399476, is classified under NAICS 813920 Professional Organizations and PSC R420 SUPPORT- PROFESSIONAL: CERTIFICATIONS AND ACCREDITATIONS (OTHER THAN EDUC OR INFO TECH C&A). There is no set-aside for this action, and the agency intends to award the contract under the authority of FAR 13.106(b)(1).
The performance period consists of a one-year base period from October 1, 2026, to September 30, 2027, followed by two option years extending through September 30, 2029. While this notice is not a request for competitive quotes, the government will consider capability statements from responsible sources that demonstrate the ability to provide accreditation for a bone marrow transplant organization meeting or exceeding FACT standards. All submissions are due by May 20, 2026, and will be evaluated by the agency prior to the intended award date of May 22, 2026.
Darlena Rivera serves as the primary point of contact for this requirement located in the United States. There are zero attachments associated with this special notice. The determination to proceed with a sole source award remains at the discretion of the government, and information submitted by interested parties will not be utilized for a subsequent solicitation requirement or as a basis for reimbursement.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.